Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-26-078583
Filing Date
2026-06-29
Accepted
2026-06-29 09:18:18
Documents
17
Effectiveness Date
2026-06-29

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2618985d1_s8.htm S-8 73030
2 EXHIBIT 5.1 tm2618985d1_ex5-1.htm EX-5.1 7577
3 EXHIBIT 23.1 tm2618985d1_ex23-1.htm EX-23.1 2781
4 EX-FILING FEES tm2618985d1_ex-filingfees.htm   iXBRL EX-FILING FEES 20688
5 GRAPHIC image_001.gif GRAPHIC 73
6 GRAPHIC tm2618985d1_ex5-1img001.jpg GRAPHIC 13540
7 GRAPHIC tm2618985d1_ex5-1img003.jpg GRAPHIC 846
8 GRAPHIC tm2618985d1_ex5-1img004.jpg GRAPHIC 860
  Complete submission text file 0001104659-26-078583.txt   254711

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2618985d1_ex-filingfees_htm.xml XML 7748
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-297099 | Film No.: 261131587
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)